Policy & Regulation
Sosei Heptares signs research collaboration and license agreement with Genentech to discover and develop novel medicines
16 July 2019 - Biopharmaceutical company Sosei Group Corporation (TSE:4565) on Tuesday announced a multi-target research collaboration and license agreement with Genentech, a member of the Roche Group...
Bayer wins US FDA approval for Gadato to assess myocardial perfusion and late gadolinium enhancement in adult patients with CAD
16 July 2019 - Healthcare company Bayer reported on Monday the receipt of US Food and Drug Administration (FDA) approval for Gadavist (gadobutrol) injection for use in cardiac magnetic resonance (MR) ...
ESSA Pharma names new chief medical officer
16 July 2019 - ESSA Pharma Inc (NASDAQ: EPIX)( TSX-V: EPI), a pharmaceutical company focused on the developing novel therapies for the treatment of prostate cancer, announced yesterday that it has nam...
AstraZeneca provides update on decision by US FDA for Farxiga in type-1 diabetes
16 July 2019 - AstraZeneca Plc (LON:AZN), a global, science-led biopharmaceutical company, announced on Monday the issue by the US Food and Drug Administration (FDA) of a complete response letter rega...
Gilead Sciences signs 10-year global research and development collaboration with Galapagos
16 July 2019 - Gilead Sciences, a biopharmaceutical company, has signed a 10-year global research and development collaboration with Belgium-based Galapagos, it was reported yesterday.According to the...
Orphazyme appoints new CEO
16 July 2019 - Orphazyme A/S (CPH:ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, announced on Monday the appointment of Kim Stratton ...